Decay of anti-Bordetella pertussis antibodies in women of childbearing age following COVID-19 non-pharmaceutical measures

This publication has 25 references indexed in Scilit:

• The Decline of Pertussis-Specific Antibodies After Tetanus, Diphtheria, and Acellular Pertussis Immunization in Late Pregnancy
  The Journal of Infectious Diseases, 2015
• The effect of timing of maternal tetanus, diphtheria, and acellular pertussis (Tdap) immunization during pregnancy on newborn pertussis antibody levels – A prospective study
  Vaccine, 2014
• What to do and what not to do in serological diagnosis of pertussis: recommendations from EU reference laboratories
  European Journal of Clinical Microbiology & Infectious Diseases, 2010
• Seroprevalence ofBordetella pertussisInfection during Pregnancy Measured by IgG Antibodies against Pertussis Toxin
  Clinical Infectious Diseases, 2009
• Pathology and Pathogenesis of FatalBordetella pertussisInfection in Infants
  Clinical Infectious Diseases, 2008
• Pertussis Serostatus among Neonates Born to Hispanic Women
  Clinical Infectious Diseases, 2006
• Bordetella bronchisepticaAdherence to Cilia Is Mediated by Multiple Adhesin Factors and Blocked by Surfactant Protein A
  Infection and Immunity, 2005
• Immune Responses and Antibody Decay after Immunization of Adolescents and Adults with an Acellular Pertussis Vaccine: The APERT Study
  The Journal of Infectious Diseases, 2004
• Frequency of Unrecognized Bordetella pertussis Infections in Adults
  Clinical Infectious Diseases, 1995
• Pertactin, an Arg-Gly-Asp-containing Bordetella pertussis surface protein that promotes adherence of mammalian cells.
  Proceedings of the National Academy of Sciences, 1991